Francesca Alvarez-Calderon, Ph.D.
Affiliations: | 2013 | Immunology | University of Colorado Anschutz Medical Campus, Denver, Aurora, CO |
Area:
OncologyGoogle:
"Francesca Alvarez-Calderon"Mean distance: 6635.5
Parents
Sign in to add mentor| James V DeGregori | grad student | 2013 | University of Colorado, Denver | |
| (Tyrosine kinase inhibition results in mitochondrial metabolic addictions in leukemia.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Gregory MA, D'Alessandro A, Alvarez-Calderon F, et al. (2016) ATM/G6PD-driven redox metabolism promotes FLT3 inhibitor resistance in acute myeloid leukemia. Proceedings of the National Academy of Sciences of the United States of America. 113: E6669-E6678 |
| Alvarez-Calderon F, DeGregori J. (2015) Oncogenic drivers and mitochondrial dependency. Aging. 7: 148-9 |
| Alvarez-Calderon F, Gregory MA, Pham-Danis C, et al. (2015) Tyrosine kinase inhibition in leukemia induces an altered metabolic state sensitive to mitochondrial perturbations. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 1360-72 |
| Gregory MA, D'Alessandro A, Alvarez-Calderon F, et al. (2015) Abstract C78: ATM/G6PD-dependent metabolic pathways promote mitochondrial redox homeostasis and resistance to FLT3 inhibition in acute myeloid leukemia Molecular Cancer Therapeutics. 14 |
| Christoph S, Schlegel J, Alvarez-Calderon F, et al. (2013) Bioluminescence imaging of leukemia cell lines in vitro and in mouse xenografts: effects of monoclonal and polyclonal cell populations on intensity and kinetics of photon emission. Journal of Hematology & Oncology. 6: 10 |
| Alvarez-Calderon F, Gregory MA, DeGregori J. (2013) Using functional genomics to overcome therapeutic resistance in hematological malignancies. Immunologic Research. 55: 100-15 |
| Alvarez-Calderon F, Zaberezhnyy V, Gemta L, et al. (2012) Abstract 1127: Bcr-Abl inhibition in leukemia cells creates metabolic addictions Cancer Research. 72: 1127-1127 |
| Alvarez-Calderon F, Gregory MA, DeGregori J. (2011) Abstract 3796: Inhibition of mitochondrial respiration synergizes with tyrosine kinase inhibitors to eliminate Bcr-Abl+ leukemia Cancer Research. 71: 3796-3796 |
| Gregory MA, Phang TL, Neviani P, et al. (2010) Wnt/Ca2+/NFAT signaling maintains survival of Ph+ leukemia cells upon inhibition of Bcr-Abl. Cancer Cell. 18: 74-87 |